China Vows Closer Oversight Of Heparin Producers

Law360, New York (March 21, 2008, 12:00 AM EDT) -- China's drug safety agency changed course Friday in response to the U.S. Food and Drug Administration's discovery that a dangerous contaminant in heparin could be traced to Chinese suppliers, saying that it would tighten controls on heparin production.

China's State Food and Drug Administration has reportedly posted a note on its Web site that heparin producers would be required to use only registered suppliers in an effort to prevent another round of contamination. The blood-thinning drug has been linked to 19 deaths and hundreds of allergic...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.